Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA
Six unproven peptides popular with MAHA now under "enforcement discretion policy."
Robert F. Kennedy Jr., the Health Secretary for Make America Health Again, has unilaterally granted special access to specialty pharmacies to sell six specific peptide drugs, bypassing the Food and Drug Administration's (FDA) previous decision. These peptides, often favored by Kennedy and his allies, are controversial as scientists at the FDA maintain there is insufficient evidence to prove their effectiveness and potential danger.
The FDA previously removed these peptides from the list of drugs that can be compounded by pharmacies. However, Kennedy's new rule, titled "Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances," issued on October 30, essentially removes the FDA's ability to enforce regulations against pharmacies producing and selling these peptides.
The rule does not alter the peptides' status but allows compounding pharmacies to bypass federal regulation and freely produce and sell them.
Written by urgent.news from Ars Technica Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
